|
WO2020051566A1
|
|
Vaccines with enhanced immune response and methods for their preparation
|
|
WO2015175361A1
|
|
Dengue virus specific multiple hla binding t cell epitopes for the use of universal vaccine development
|
|
WO2015130488A2
|
|
Mhc class i associated peptides for prevention and treatment of hepatitis b virus infection
|
|
WO2013059403A1
|
|
Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of influenza virus infection
|
|
EP3228321A2
|
|
Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
AU2012275319A1
|
|
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of Dengue virus infection
|
|
WO2011025572A1
|
|
Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
WO2009036246A2
|
|
Immunogens that induce cytotoxic t-lymphocytes and their use in prevention, treatment, and diagnosis of cancer
|
|
WO2008070047A2
|
|
Immunogens in cancer stem cells
|
|
US2008107668A1
|
|
Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
US2008207497A1
|
|
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
